BAM Management, LLC

Latest statistics and disclosures from BAM Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ONTY, BPAX, Genvec Inc, RXII, and represent 100.00% of BAM Management's stock portfolio.
  • Added to shares of these 3 stocks: ONTY, BPAX, Genvec Inc.
  • Reduced shares in these 1 stocks: RXII.
  • BAM Management was a net buyer of stock by $5.21M.
  • BAM Management has $12.95M in assets under management (AUM), growing by 20.96%.

BAM Management portfolio companies for September 2011 quarter

Company (Ticker) Portfolio Weight Share Count Price Last Trade
Oncothyreon (ONTY) 57.60 1.25M +66.00% 5.98 1.60
BioSante Pharmaceuticals (BPAX) 38.60 2.19M +89.00% 2.28 0.00
Genvec Inc 2.42 109024 +20.00% 2.87 0.00
RXi Pharmaceuticals Corporation (RXII) 1.38 177406 -51.00% 1.01 1.16

Past 13F-HR SEC Filings for BAM Management

View All Filings